Home › Funds › DAFNA Capital Management LLC › LKFT

DAFNA Capital Management LLC position in LKFT

LAKEFRONT BIOTHERAPEUTICS NV

DAFNA Capital Management LLC reported holding 130,175 shares of LKFT (LAKEFRONT BIOTHERAPEUTICS NV) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 0.74% of its reported portfolio and ranking #31 among its reported holdings. DAFNA Capital Management LLC has disclosed LKFT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)130.18K sh
Reported value held$3.90M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's LKFT position evolved

DAFNA Capital Management LLC first disclosed a stake in LKFT in Q3 2023 at 60,175 shares (US$2.1M). The position peaked in Q4 2023 at 130,175 shares, worth US$5.3M. Across 12 filings, DAFNA Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 130,175 shares valued at US$3.9M. Notable position changes include a 116% increase in Q4 2023 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 60.17K $2.08M New
Q4 2023 130.18K $5.29M Add
Q1 2024 130.18K $4.19M Hold
Q2 2024 130.18K $3.23M Hold
Q3 2024 130.18K $3.75M Hold
Q4 2024 130.18K $3.58M Hold
Q1 2025 130.18K $3.27M Hold
Q2 2025 130.18K $3.64M Hold
Q3 2025 130.18K $4.51M Hold
Q4 2025 130.18K $4.26M Hold
Q1 2026 130.18K $3.91M Hold
Q2 2026 130.18K $3.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LKFT and 13F data

LKFT (LAKEFRONT BIOTHERAPEUTICS NV) is a company whose sector is not yet classified in our data. 17 other funds we track also report a position in LKFT — the largest reported positions include GILEAD SCIENCES, INC. (US$500.2M), TANG CAPITAL MANAGEMENT LLC (US$113.5M), Madison Avenue Partners, LP (US$103.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LKFT

All LKFT fund holders →

FAQ

How long has DAFNA Capital Management LLC held LKFT?

DAFNA Capital Management LLC has disclosed LKFT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DAFNA Capital Management LLC's current position in LKFT?

As of Q2 2026, DAFNA Capital Management LLC holds 130.18K shares of LKFT (LAKEFRONT BIOTHERAPEUTICS NV), valued at $3.90M, representing 0.74% of its reported portfolio and ranking #31.

Has DAFNA Capital Management LLC been buying or selling LKFT?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC held unchanged its position in LKFT. The position peaked in Q4 2023 at 130.18K shares.

Which other funds hold LKFT?

Other major institutional holders of LKFT include GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.